Vascular Access for Hemodialysis and Value-Based Purchasing for ESRD.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution.The Journal of international medical research · 2019
   Trial
2. Influence of Tunneled Hemodialysis-Catheters on Inflammation and Mortality in Dialyzed Patients.International journal of environmental research and public health · 2021
   Article
3. The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential.American journal of physiology. Renal physiology · 2018
   Article

Corrections and comments

• Comment on
  The Survival Benefit of "Fistula First, Catheter Last" in Hemodialysis Is Primarily Due to Patient Factors.2017
• Comment on
  The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death.2017

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as